This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Injectable contraceptives

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Injectable hormonal contraceptives are slow release, long lasting progesterone preparations administered i.m. at intervals from 1 to 6 months. Common preparations include medroxyprogesterone acetate and norethisterone enanthate.

The main disadvantages are due to the progesterone. Many experience some degree of menstrual disturbance; in some, this can be irregular uterine bleeding which may be heavy and prolonged whilst others may experience amenorrhoea.

Injectable contraception however, may be particularly suited:

  • following rubella vaccination in the puerperium
  • while awaiting for vasectomy to be proven in a partner
  • in women with a chaotic lifestyle where taking an oral contraceptive regularly is difficult

Injectable hormonal contraception has a failure rate of 1 in 1000. Thus this form of contraception is more effective than the combined pill and female sterilisation (1 in 200 failure rate) (1).


  • (1) Prescriber (2001), 12 (5), 83-95.
  • (2) BNF 7.3

Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page